HARS2 and hepatocellular carcinoma: However, in the present study, it was the first time that the expressions of these NMRGs, including HARS2, MPV17, MTFMT, C12ORF65, FRDA, CARS2, VARS2, and CABC1, were found to have influence on the progression of HCC patients.